Center-Authored Papers

Filters: Author is Moreno-Aspitia, Alvaro  [Clear All Filters]
G
Gingras I, Holmes E, de Azambuja E, Nguyen DHA, Izquierdo M, Zujewski JA, Inbar M, Naume B, Tomasello G, Gralow JR et al..  2017.  Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.. Journal of the National Cancer Institute. 109(8) Abstract
M
Moreno-Aspitia A, Hillman DW, Dyar SH, Tenner KS, Gralow J, Kaufman PA, Davidson NE, Lafky JM, Reinholz MM, Lingle WL et al..  2013.  Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831.. Cancer. Abstract
S
Sonnenblick A, Agbor-Tarh D, Bradbury I, Di Cosimo S, Azim HA, Fumagalli D, Sarp S, Wolff AC, Andersson M, Kroep J et al..  2017.  Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2016697722. Abstract